Physician profile
Arshdeep Sandhu
NPI 1730593146
$555.49
in general payments reported to CMS, 2019-2025
11 companies · $443 in 2025
The $443 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $113 · 2025: $443.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $555.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $555.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $129.00 | 2025 | Airsupra |
| Astellas Pharma US INC | $124.38 | 2025 | Veozah |
| Exact Sciences Corporation | $90.75 | 2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $42.55 | 2024 | |
| Lilly USA, LLC | $41.68 | 2024-2025 | Mounjaro, Zepbound |
| Novo Nordisk INC | $31.77 | 2024-2025 | Rybelsus, Ozempic, Wegovy |
| Boston Scientific Corporation | $22.86 | 2024 | Watchman Flx |
| Eisai INC. | $20.53 | 2025 | |
| Sumitomo Pharma America, INC. | $19.67 | 2025 | Gemtesa |
| Pfizer INC. | $17.19 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $15.11 | 2024 | Zoryve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arshdeep Sandhu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.